← BackIngevity Corp · Chemicals & Allied ProductsNGVT
Moderate riskNext report: Around Nov 4 (est.)
The short versionA company still losing money with shrinking sales.
Going well
- Buying back shares: share count down 5.8% in 3 years
Watch out for
- Losing money
- Debt above equity: 1.59x
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 1.8% from their holdings in the quarter ending June 2026 (145 bought, 134 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$71.09+2.1% that day
- Company value
- $2.4B
- Share price times all shares
- Price vs profit (P/E)
- 47.4x
- You pay about $47 for each $1 of yearly profit
- Price vs sales
- 2.1x
- Company value is 2.1 times a year of sales
- Cash vs value
- 4%
- Cash as a share of company value
- Debt vs value
- 2%
- Debt as a share of company value
From NGVT's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$314.1M-5.2% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $1.2B, down 1.4% from the 12 months before. Over 5 years, sales shrank about 0.8% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-148.6%
- MissDebt under half of equityNot relying on borrowed money.1.59x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-14.3%
- MissProfitable every yearSteady profits, not one good year.7 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$331.2M
- PassShare count not growingNot diluting owners. Falling means buybacks.-5.8% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.39.5%
- Revenue
- $1.2B
- -2.7% vs prior year
- 5-year growth
- -0.8%/yr
- revenue, per year
- Total debt
- $47.1M
- 1.59x equity
- Current ratio
- 1.33x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $314.1M
- -5.2% YoY
- EPS
- $1.00
- vs -$4.02
- Gross margin
- 44.3%
- +5.7 pts
- Free cash flow
- -$24.1M
- Share count
- -3.2%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.9
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-1.8%Institutions cut 1.8% from their holdings. 145 bought, 134 sold. 2 quarters of net selling in a row.
Shares held by institutions35.1M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-1.7%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
22.5x · $1.1B debtShares outstandingLatest reported
34MWhy moderate risk- Losing money
- High debt: 22.52x equity
Next reportAround Nov 4 (est.)Estimated from the same quarter last year
- Results filedJul 29
- Results filedMay 6
- Results filedFeb 25
- Results filedNov 5, 2025
- Results filedAug 4, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
Stock awardJ Kevin WillisDirector
405 shares at $71.09 · $29K
- +4% of holdings
- Now owns 11,883 shares
- Filed 1 day after trade
Stock awardFrancis David SegalDirector
335 shares at $71.09 · $24K
- +4% of holdings
- Now owns 8,947 shares
- Filed 1 day after trade
SoldDavid H LiPresident & CEO, Director
10,092 shares at $75.77 avg ($74.71 to $75.83) · $765K
- -8% of holdings
- Now owns 120,544 shares
- Pre-planned sale (10b5-1)
- 3 transactions
- Filed same day
SoldDavid H LiPresident & CEO, Director
10,000 shares at $76.18 avg ($75.73 to $76.62) · $762K
- -7% of holdings
- Now owns 130,636 shares
- Pre-planned sale (10b5-1)
- 2 transactions
- Filed 1 day after trade
Shares withheld for taxesPhillip John PlattSVP, Chief Financial Officer
1,698 shares at $77.04 · $131K
- -6% of holdings
- Now owns 26,641 shares
- Filed 1 day after trade
SoldRyan C. FisherSVP, Gen. Counsel & Secretary
2,709 shares at $73.72 avg ($73.67 to $73.76) · $200K
- -15% of holdings
- Now owns 15,722 shares
- Not a pre-planned sale
- 2 transactions
- Filed 1 day after trade